A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 833
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LC
Long Form : lung cancer
No. Year Title Co-occurring Abbreviation
2020 A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis. ---
2020 Analysis of the Expression of Cell Division Cycle-Associated Genes and Its Prognostic Significance in Human Lung Carcinoma: A Review of the Literature Databases. CDCA, PPS
2020 Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis. HRCT, IPF
2020 Certain interleukin polymorphisms might influence predisposition to lung cancer: A meta-analysis of 35 published studies. ---
2020 Chromate exposure induces DNA hypermethylation of the mismatch repair gene MLH1 in lung cancer. MSI
2020 Coagulation factor IV is an indicator of symptomatic pulmonary embolism in patients with primary lung cancer. AUC, LCPE, PE, SIC, STC
2020 Comparative analysis of the human serum N-glycome in lung cancer, COPD and their comorbidity using capillary electrophoresis. COPD
2020 Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. ceRNA, DE, GO, lncRNAs, LUAD, LUSC, miRNA, WGCNA
2020 Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier. cfDNA, CNV, XGBoost
10  2020 Diagnostic performance of the bronchial aspirate collected before and after the bronchial biopsy in patients with pulmonary neoplasia with endobronchial lesion. BASpre
11  2020 Dormancy and NKG2D system in brainmetastases: Analysis of immunogenicity. BC, NKG2D, NKG2DL
12  2020 Effectiveness and Feasibility of Complementary Lung-RADS Version 1.1 in Risk Stratification for pGGN in LDCT Lung Cancer Screening in a Chinese Population. FNP, GVR, LDCT, Lung-RADS, pGGNs
13  2020 EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells. DCs, LLC, LNs
14  2020 Epidemiological evidence for associations between variants in microRNA or biosynthesis genes and lung cancer risk. miRNAs, SNPs
15  2020 Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review. ICM, RN, RT, SRS
16  2020 Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma. BC, ED, FN, LOS, NHL
17  2020 GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling. SLC2A5
18  2020 Green synthesis of quaternized chitosan/silver nanocomposites for targeting mycobacterium tuberculosis and lung carcinoma cells (A-549). SPR
19  2020 High Expression of CARM1 Inhibits Lung Cancer Progression by Targeting TP53 by Regulating CTNNB1. ---
20  2020 Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study. GHS, HR, HR, HR, HRQoL, RF, SF
21  2020 Integration Of IgA and IgG Autoantigens Improves Performance Of Biomarker Panels For Early Diagnosis Of Lung Cancer. LBL
22  2020 Intensity of care, expenditure, place and cause of death people with lung cancer in the year before their death: A French population based study. HPC, SSH
23  2020 Investigation of key miRNAs and potential mechanisms in non-small cell lung cancer development from chronic obstructive pulmonary disease. COPD, DEGs, NSCLC
24  2020 Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment. ART, DDIs, HIV, PLWH
25  2020 Lung cancer in never smokers: The role of different risk factors other than tobacco smoking. ---
26  2020 Lung Cancer Screening: Patient Selection and Implementation. ---
27  2020 Machine Learning and Bioinformatics Models to Identify Pathways that Mediate Influences of Welding Fumes on Cancer Progression. CC, Cox PH, GC, PC, PL, WFs
28  2020 Myeloid-derived suppressor cells-new and exciting players in lung cancer. MDSCs
29  2020 Non-coding RNA and lung cancer progression. circRNAs, EGFR, lncRNAs, miRNAs, ncRNAs, VEGF
30  2020 Restoration of Mal overcomes the defects of apoptosis in lung cancer cells. FasL, LPS, NC, TLR
31  2020 Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. AUC, ELISA, TAAs
32  2020 Two-step investigation of lung cancer detection by sniffing dogs. IEO, VOCs
33  2019 A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer. AUC, BLD, NC, TAAs
34  2019 A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer. BC, SPM, WT
35  2019 Acanthopanax senticosus polysaccharide suppressing proliferation and metastasis of the human non-small cell lung cancer NCI-H520 cells is associated with Wnt/beta-catenin signaling. AS, ASPS, CCK-8, EMT, FN1, MMP-2, NSCLC, p-GSK3beta, qRT-PCR
36  2019 Advanced multimodal diagnostic approaches for detection of lung cancer. AI, MIPs, NSCLC
37  2019 Adverse effects observed in lung cancer patients undergoing first-line chemotherapy and effectiveness of supportive care drugs in a resource-limited setting. AEs, SCMs
38  2019 An TRIM59-CDK6 axis regulates growth and metastasis of lung cancer. CDK6, EMT, ERK
39  2019 Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis. CDKs, NSCLC
40  2019 Association between Polymorphisms of Vitamin D Receptor and Lung Cancer Susceptibility: Evidence from an Updated Meta-analysis. FEM, REM, VDR
41  2019 Association of neurologic manifestations and CEA levels with the diagnosis of brain metastases in lung cancer patients. BM
42  2019 Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer. RCT, RIET
43  2019 Association of the Promoter Methylation and the rs12917 Polymorphism of MGMT with Formation of DNA Bulky Adducts and the Risk of Lung Cancer in Mexican Mestizo Population. MGMT
44  2019 Associations between Folate Metabolism Enzyme Polymorphisms and Lung Cancer: A Meta-Analysis. ---
45  2019 ATM rs189037 significantly increases the risk of cancer in non-smokers rather than smokers: an updated meta-analysis. ATM, CIs, ORs
46  2019 Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review. ELISA, TAAbs, WT1
47  2019 Bronchoalveolar Lavage Fluid-Derived Exosomes: A Novel Role Contributing to Lung Cancer Growth. BALF, NTHi
48  2019 C-reactive protein gene 1846C>T polymorphism is associated with increased risk and clinical features of lung cancer: a case-control study. CRP, PCR-RFLR
49  2019 Chemotherapy-associated Acute Exacerbation of Interstitial Lung Disease Shortens Survival Especially in Small Cell Lung Cancer. AE-ILD, ILD, SCLC
50  2019 Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations. AUC
51  2019 Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. miRNAs, NSCLC
52  2019 Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis. ORs, PE, WMDs
53  2019 Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease. APTT, DD, FIB, IL-6, LMWH, PCT, PT, TE
54  2019 Corrigendum to "Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter?" [Crit. Rev. Oncol. Hematol. 138 (June) (2019), 87-103]. ---
55  2019 Could microRNA be used as a diagnostic tool for lung cancer? AUC, miRNA, NLR, PLR
56  2019 Decreased Levels of Histidine-Rich Glycoprotein in Advanced Lung Cancer: Association with Prothrombotic Alterations. CLT, ED, HRG
57  2019 Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer. EBV, NGS
58  2019 Diagnosis of solitary pulmonary lesions withintravoxel incoherent motion diffusion-weighted MRI and semi-quantitative dynamic contrast-enhanced MRI. DCE-MRI, DWI, IVIM, MER, MRI, ROC, SPLs, TICs
59  2019 Diagnostic value of plasma expression of microRNAs complementary to Drosha and Dicer in lung cancer patients. ---
60  2019 Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer. AUC, ELISA, SEREX, TAAs
61  2019 Dysbiosis of the Gut Microbiome in Lung Cancer. ---
62  2019 Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model. OPLS
63  2019 Effects of high-quality nursing care for patients with lung cancer during the perioperative period: A protocol of systematic review of randomized controlled trials. HQNC, PPP
64  2019 Effects of tanshinones mediated by forkhead box O3a transcription factor on the proliferation and apoptosis of lung cancer cells. CON, FOXO3a, siRNA, Ts
65  2019 End-of-Life Health Care Utilization Between Chronic Obstructive Pulmonary Disease and Lung Cancer Patients. COPD
66  2019 Endoplasmic reticulum stress and unfolded protein response profile in quadriceps of sarcopenic patients with respiratory diseases. ATF, COPD, ER, FFMI, IRE, PERK, UPR, VL
67  2019 Epidemiological Study of Lung Cancer Incidence in Lebanon. MENA
68  2019 Epidemiology and diagnosis of pulmonary embolism in lung cancer patients: is there a role for age adjusted D-dimers cutoff? CTPA, D-D, ED, OC, PE
69  2019 Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank. BALF, COPD, EBC, ELISA, eurIPFreg, HP, ILD, IPF
70  2019 FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients. A/CS, NSCLC
71  2019 G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey. BC, FN, FN-HR, GL, HR, IR
72  2019 Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility. OR, SNPs
73  2019 Genetic effects of welding fumes on the development of respiratory system diseases. AS, CB, DEGs, PE, RSDs, WF
74  2019 Genetic polymorphisms in IL-7 and IL-7R are correlated with lung cancer risk in the Chinese Han population. LD, SNPs
75  2019 Genetic variants of DNA repair pathway genes on lung cancer risk. DNA
76  2019 Health benefit assessment of PM2.5 reduction in Pearl River Delta region of China using a model-monitor data fusion approach. BenMAP-CE, CMAQ, COPD, IHD, PRD
77  2019 Heterogeneous tumor features and treatment outcome between males and females with lung cancer (LC): Do gender and sex matter? ---
78  2019 Human papillomavirus and lung cancer: an overview and a meta-analysis. HPV
79  2019 Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma. GSEA, LUAD, OS
80  2019 Identification of differentially expressed genes between primary lung cancer and lymph node metastasis via bioinformatic analysis. DEGs, MLNM, MM LC, OS, PPI
81  2019 Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. IPF, NSCLC
82  2019 Immunotherapy with Monoclonal Antibodies in Lung Cancer of Mice: Oxidative Stress and Other Biological Events. ---
83  2019 Impact of comprehensive geriatric assessment on short-term mortality in older patients with cancer-a follow-up study. CGA, CRC, HNC, OR, UGI
84  2019 Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion. ---
85  2019 Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening. CI, SIR, TCC
86  2019 Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. BC
87  2019 Integration of metabolomic and transcriptomic profiles to identify biomarkers in serum of lung cancer. GC-MS, PLS-DA
88  2019 Liquid Biopsies in Lung Cancer: Four Emerging Technologies and Potential Clinical Applications. CNI, CTC
89  2019 LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway. CCK-8, lncRNA, NSCLC, qRT-PCR
90  2019 Loss of stretch-activated channels, PIEZOs, accelerates non-small cell lung cancer progression and cell migration. LUAD, LUSC, NSCLC, OS
91  2019 Lung cancer in Mexico: findings from the Global Burden of Disease Study, 1990-2016. DALYs, SDI
92  2019 Lung cancer mortality and municipal marginalization in Mexico, 1998-2016. INEGI, MMI
93  2019 Lung Cancer Screening: Use of Low-Dose Computed Tomography. LDCT
94  2019 Lung cancer survivors and employment: A systematic review. PRISMA
95  2019 Lung Molecular Cytopathology: EGFR and Beyond. ALK, EGFR, NSCLC, PD-L1, ROS1
96  2019 MARKERS OF THE LUNG CANCER COMPLICATIONS. ---
97  2019 Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology. CKI, PPI
98  2019 Metabolomic study of serum, urine and bronchoalveolar lavage fluid based on gas chromatography mass spectrometry to delve into the pathology of lung cancer. BALF, GC-MS, HC, NCC
99  2019 Meteorological correlates and AirQ+ health risk assessment of ambient fine particulate matter in Tehran, Iran. ALRI, COPD, IHD
100  2019 Methylation Assessment for the Prediction of Malignancy in Mediastinal Adenopathies Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Patients with Lung Cancer. EBUS-TBNA